102 related articles for article (PubMed ID: 6396561)
21. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
22. A multicentre phase II trial of vindesine in malignant melanoma.
Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
[TBL] [Abstract][Full Text] [Related]
23. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
[No Abstract] [Full Text] [Related]
25. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
26. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
27. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of vindesine in advanced head and neck cancer.
Cheng E; Young CW; Wittes RE
Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
[TBL] [Abstract][Full Text] [Related]
29. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
30. Vindesine in bronchogenic carcinoma: a phase II trial.
Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
[TBL] [Abstract][Full Text] [Related]
31. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
Garewal HS; Brooks RJ; Jones SE; Miller TP
J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
[TBL] [Abstract][Full Text] [Related]
32. Comparison of in vitro and in vivo effects of vincristine and vindesine on leukemic cells from patients with chronic granulocytic leukemia in blast crisis.
Theodorakis ME; Goldberg J
Leuk Res; 1984; 8(6):1065-71. PubMed ID: 6595480
[TBL] [Abstract][Full Text] [Related]
33. Phase II evaluation of vindesine in patients with advanced breast cancer.
Currie VE; Camacho F; Wittes R; Young C
Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
[No Abstract] [Full Text] [Related]
34. Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Grozea PN; Fabian CJ; Dixon DO
Cancer Treat Rep; 1984; 68(7-8):963-7. PubMed ID: 6744347
[TBL] [Abstract][Full Text] [Related]
35. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
[TBL] [Abstract][Full Text] [Related]
36. Initial clinical studies of vindesine.
Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
[TBL] [Abstract][Full Text] [Related]
37. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
[TBL] [Abstract][Full Text] [Related]
38. Continuous vindesine infusion in advanced head and neck cancer.
Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
[TBL] [Abstract][Full Text] [Related]
39. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of vindesine in metastatic malignant melanoma.
Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
